Pfizer has won the battle to take control of obesity drug developer Metsera, after rival Novo Nordisk said that it would not increase its offer for the company above $10 billion.After a frenetic few days that started with an unsolicited bid by Danish group Novo Nordisk that tried to entice Metsera away from its September […]
